Select all docs (Max 200)
Narrow Results:
Publication Year
Medical Subject
- Adolescent 3
- Adult 3
- Antibodies, Neutralizing 1
- Antibodies, Viral 3
- Article 2
- Child, Preschool 1
- Clinical Laboratory Techniques 1
- COVID-19 1
- Disease Eradication 1
- Disease Outbreaks 1
- Feces 1
- Female 4
- Global Health 1
- Humans 5
- Immunization 1
- Immunoglobulin G 2
- Infant 1
- Infant, Newborn 1
- Logistic Models 1
- Male 2
- Measles 1
- Measles Vaccine 1
- Namibia 3
- Nigeria 1
- Patient Acceptance of Health Care 1
- Poliomyelitis 3
- PolioVirus 1
- Poliovirus 1
- Poliovirus Vaccines 2
- PolioVirus Vaccines 1
- Population immunity 2
- Population Surveillance 1
- Pregnancy 3
- Pregnant women 2
- Rubella 1
- Rubella Vaccine 1
- Seroepidemiologic Studies 1
- Seroprevalence 2
- Vaccination 3
- Young Adult 3
Personal Author
Place as Subject
- Namibia 1
Resource Type General
Keywords
- Adolescent 1
- Adult 1
- adults 1
- Case-Control Studies 1
- Cohort Studies 1
- eradication 1
- evaluation 1
- Female 1
- fetal outcome 1
- HIV 1
- Humans 1
- immunization 1
- Incidence 1
- Infant, Newborn 1
- Male 1
- maternal morbidity 1
- Measles 1
- measles 1
- Measles virus 1
- microplanning 1
- Namibia 2
- neonatal outcome 1
- neutralizing antibody 1
- Nigeria 1
- OPV 1
- outbreak 1
- polio 2
- Poliovirus 1
- population immunity 1
- Pregnancy 1
- pregnancy 1
- Pregnancy Complications, Infectious 1
- pregnant women 1
- Retrospective Studies 1
- seroprevalence 1
- social mobilization 1
- structured observation 1
- survey 1
- Survival Analysis 1
- Treatment Outcome 1
- Young Adult 1
Select all docs (Max 200)
1 -
6 of 6 Results
SELECT A RANGE
SELECT A FORMAT
Refine Results
Refine Results:
- Adolescent (3)
- Adult (3)
- Antibodies, Neutralizing (1)
- Antibodies, Viral (3)
- Article (2)
- Child, Preschool (1)
- Clinical Laboratory Techniques (1)
- COVID-19 (1)
- Disease Eradication (1)
- Disease Outbreaks (1)
- Feces (1)
- Female (4)
- Global Health (1)
- Humans (5)
- Immunization (1)
- Immunoglobulin G (2)
- Infant (1)
- Infant, Newborn (1)
- Logistic Models (1)
- Male (2)
- Measles (1)
- Measles Vaccine (1)
- Namibia (3)
- Nigeria (1)
- Patient Acceptance of Health Care (1)
- Poliomyelitis (3)
- PolioVirus (1)
- Poliovirus (1)
- Poliovirus Vaccines (2)
- PolioVirus Vaccines (1)
- Population immunity (2)
- Population Surveillance (1)
- Pregnancy (3)
- Pregnant women (2)
- Rubella (1)
- Rubella Vaccine (1)
- Seroepidemiologic Studies (1)
- Seroprevalence (2)
- Vaccination (3)
- Young Adult (3)
- Adolescent (1)
- Adult (1)
- adults (1)
- Case-Control Studies (1)
- Cohort Studies (1)
- eradication (1)
- evaluation (1)
- Female (1)
- fetal outcome (1)
- HIV (1)
- Humans (1)
- immunization (1)
- Incidence (1)
- Infant, Newborn (1)
- Male (1)
- maternal morbidity (1)
- Measles (1)
- measles (1)
- Measles virus (1)
- microplanning (1)
- Namibia (2)
- neonatal outcome (1)
- neutralizing antibody (1)
- Nigeria (1)
- OPV (1)
- outbreak (1)
- polio (2)
- Poliovirus (1)
- population immunity (1)
- Pregnancy (1)
- pregnancy (1)
- Pregnancy Complications, Infectious (1)
- pregnant women (1)
- Retrospective Studies (1)
- seroprevalence (1)
- social mobilization (1)
- structured observation (1)
- survey (1)
- Survival Analysis (1)
- Treatment Outcome (1)
- Young Adult (1)
- :Ogbuanu, Ikechukwu U. ;Zeko, Sikota4 2014 | Clin Infect Dis. 58(8):1086-1092:Background.Previous studies of maternal, fetal, and neonatal complications of measles during pregnancy suggest the possibility of increased risk for m...
- :Cardemil, Cristina V. ;Jonas, AnnaMay 24 2016 | Int J Infect Dis. 49:189-195:Background:Namibia experienced a large measles outbreak starting in 2009, with 38% of reported cases in adults, including women of reproductive age. P...
- :Jonas, Anna ;Cardemil, Cristina V.8 2016 | Int J Infect Dis. 49:196-201:Background:The level of rubella susceptibility among women of reproductive age in Namibia is unknown. Documenting the risk of rubella will help estima...
- :Gammino, Victoria M. ;Nuhu, Adamu11 01 2014 | J Infect Dis. 210(Suppl 1):S91-S97:Background.As 1 of 3 remaining poliovirus-endemic countries, Nigeria has become key to the global polio eradication effort. We evaluated supplemental ...
- :Cardemil, Cristina V. ;Jonas, Anna11 01 2014 | J Infect Dis. 210(Suppl 1):S136-S142:Background.Poliovirus (PV) antibody seroprevalence studies assess population immunity, verify an immunization program’s performance and vaccine effi...
- :Zomahoun, Delayo J. ;Burman, Ashley L.1 01 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR):On January 30, 2020, the World Health Organization (WHO) declared coronaVirus disease 2019 (COVID-19) a Public Health Emergency of International Conce...
Exit Notification/Disclaimer Policy
Links with this icon indicate that you are leaving the CDC website.
- The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
- Linking to a non-federal Website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
- You will be subject to the destination website's privacy policy when you follow the link.
- CDC is not responsible for Section 508 compliance (accessibility) on other federal or private websites.